V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012192 | 160015353 | 1.62 | 0 | Palliative (P) | 2021-03-03 | 2021-08-16 | Trabectedin | 02 | N | TRABECTEDIN | 101171512 |
| 160012194 | 160015354 | 1.53 | 75.8 | Palliative (P) | 2021-07-25 | 2021-08-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100568797 |
| 160012196 | 160015355 | 1.73 | 66.3 | null | 2017-02-18 | 2017-02-18 | Trabectedin | 02 | null | TRABECTEDIN | 100757136 |
| 160012199 | 160015356 | 1.72 | 61 | Palliative (P) | 2018-05-20 | 2018-05-31 | DOXORUBICIN | 02 | N | NIVOLUMAB | 101314332 |
| 160012207 | 160015357 | 1.75 | 63.4 | Palliative (P) | 2021-09-05 | 2021-09-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101712479 |
| 160012208 | 160015358 | 1.84 | 62.1 | null | 2020-03-10 | 2020-07-26 | Vinorelbine (oral) | null | null | VINORELBINE | 101610548 |
| 160012214 | 160015359 | 1.73 | 59 | Palliative (P) | 2019-07-24 | 2019-07-28 | Trabectedin | 02 | N | TRABECTEDIN | 101214477 |
| 160012217 | 160015361 | 1.63 | 71.3 | Palliative (P) | 2022-04-12 | 2022-04-25 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100824395 |
| 160012223 | 160015362 | 1.82 | 61.5 | Palliative (P) | 2019-08-16 | 2019-08-23 | VINORELBINE | N | N | VINORELBINE | 101264442 |
| 160012225 | 160015363 | 1.5 | 126.4 | Palliative (P) | 2017-02-01 | 2017-02-25 | DOXORUBICIN | 02 | N | TRABECTEDIN | 101417475 |
| 160012232 | 160015364 | 1.75 | 71.4 | Palliative (P) | 2020-03-20 | 2020-03-28 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 100614076 |
| 160012233 | 160015365 | 1.64 | null | Palliative (P) | 2020-04-13 | 2021-10-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101575449 |
| 160012234 | 160015366 | 1.68 | 85.7 | null | 2021-04-18 | 2021-05-05 | Trabectedin | 02 | null | TRABECTEDIN | 100784164 |
| 160012236 | 160015367 | 1.65 | 76.15 | Palliative (P) | 2019-07-27 | 2019-12-24 | Trabectedin | 02 | N | TRABECTEDIN | 101356224 |
| 160012241 | 160015368 | 1.83 | 107.3 | Palliative (P) | 2016-10-11 | 2016-10-14 | Doxorubicin 75mg/m2 | 02 | N | TRABECTEDIN | 100195156 |
| 160012245 | 160015369 | 1.73 | 82.7 | Palliative (P) | 2020-01-21 | 2020-02-13 | DOXORUBICIN | 02 | N | VINORELBINE | 100014571 |
| 160012251 | 160015370 | 1.68 | 92.5 | Palliative (P) | 2020-03-15 | 2020-04-04 | Trabectedin | 02 | N | TRABECTEDIN | 100720359 |
| 160012252 | 160015371 | 0 | 74.5 | null | 2020-11-25 | 2022-03-26 | Vinorelbine IV | 02 | null | VINORELBINE | 100156918 |
| 160012257 | 160015372 | null | 58.6 | Palliative (P) | 2020-02-02 | 2020-05-02 | VINORELBINE | 02 | N | VINORELBINE | 100425878 |
| 160012258 | 160015373 | 1.6 | 54.8 | null | 2017-03-12 | 2017-03-12 | Doxorubicin 75mg/m2 | N | null | DOXORUBICIN | 100230691 |
| 160012260 | 160015374 | 1.72 | 78.7 | Palliative (P) | 2021-09-09 | 2021-09-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100346698 |
| 160012264 | 160015375 | 0 | 90 | null | 2020-12-09 | 2020-12-09 | Vinorelbine (weekly iv) | 02 | null | VINORELBINE | 100607029 |
| 160012270 | 160015376 | 1.73 | 57 | null | 2017-06-24 | 2017-07-22 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101046547 |
| 160012273 | 160015377 | 1.73 | 67.95 | Palliative (P) | 2019-03-21 | 2020-02-03 | Doxorubin 50mg/m2 | null | N | DOXORUBICIN | 101600461 |
| 160012274 | 160015378 | 1.68 | 66.2 | Palliative (P) | 2021-02-27 | 2021-03-23 | Trabectedin | 02 | N | TRABECTEDIN | 100819619 |
| 160012277 | 160015379 | 1.67 | 99 | Adjuvant (A) | 2019-01-21 | 2019-02-05 | NIVOLUMAB | 02 | N | TRABECTEDIN | 101816373 |
| 160012278 | 160015380 | 1.72 | 107.8 | Palliative (P) | 2020-10-29 | 2020-11-01 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101740566 |
| 160012279 | 160015381 | 1.75 | 90.8 | null | 2019-04-09 | 2019-04-13 | Trabectedin | 02 | null | TRABECTEDIN | 100710441 |
| 160012282 | 160015382 | 1.63 | 58.8 | Palliative (P) | 2021-01-10 | 2021-01-10 | Trabectedin | 02 | N | TRABECTEDIN | 100069395 |
| 160012284 | 160015383 | 1.72 | 61.2 | Palliative (P) | 2021-02-24 | 2021-02-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101538934 |
| 160012288 | 160015384 | 1.64 | 77.4 | Palliative (P) | 2020-06-16 | 2020-12-06 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100085696 |
| 160012289 | 160015385 | 1.52 | 52 | null | 2019-01-30 | 2019-02-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100574817 |
| 160012294 | 160015386 | 1.72 | 97.7 | Palliative (P) | 2020-09-20 | 2021-01-18 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100579814 |
| 160012298 | 160015387 | 1.57 | 69.6 | Palliative (P) | 2021-12-02 | 2021-12-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100124672 |
| 160012299 | 160015388 | 1.72 | 76.1 | 03 | 2020-06-28 | 2020-07-04 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100896238 |
| 160012301 | 160015389 | 1.75 | 74.9 | Palliative (P) | 2016-10-16 | 2018-04-05 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 101789839 |
| 160012304 | 160015390 | 1.75 | 83.5 | null | 2020-10-05 | 2020-10-16 | Doxorubicin 75mg/m2 | null | null | DOXORUBICIN | 100231334 |
| 160012311 | 160015391 | 1.61 | 55.9 | Curative (C) | 2020-08-08 | 2020-08-16 | DOXORUBICIN | 02 | null | VINORELBINE | 100063852 |
| 160012320 | 160015392 | 1.85 | 76.4 | Palliative (P) | 2019-05-31 | 2019-07-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101026149 |
| 160012325 | 160015393 | 1.8 | 75.6 | Palliative (P) | 2019-10-11 | 2019-11-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100859172 |
| 160012328 | 160015394 | 1.65 | 43.2 | null | 2021-05-21 | 2021-05-21 | DOXORUBICIN | 02 | null | TRABECTEDIN | 100204964 |
| 160012329 | 160015395 | 1.72 | 61 | Palliative (P) | 2019-03-28 | 2019-05-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101335565 |
| 160012334 | 160015396 | 1.65 | null | null | 2017-12-14 | 2018-08-04 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100059008 |
| 160012364 | 160015397 | 1.75 | 90.85 | null | null | 2021-09-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100129638 |
| 160012365 | 160015398 | 1.72 | 96.8 | null | 2019-08-16 | 2019-08-17 | OST Euramos 1 Closed Trial - A | 02 | null | DOXORUBICIN | 100655541 |
| 160012371 | 160015399 | 1.65 | 73 | null | 2019-09-18 | 2019-10-04 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101140575 |
| 160012372 | 160015400 | 1.85 | 89.6 | Palliative (P) | 2021-04-03 | 2021-04-03 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100676178 |
| 160012378 | 160015401 | 1.77 | 74 | Palliative (P) | 2018-01-25 | 2018-01-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100449548 |
| 160012383 | 160015402 | 1.68 | 83.4 | null | 2021-08-15 | 2021-08-22 | Trabectedin | null | null | TRABECTEDIN | 101083907 |
| 160012385 | 160015403 | 1.83 | 82.5 | 03 | 2016-12-16 | 2017-02-12 | Doxorubicin 75mg/m2 | 2 | N | DOXORUBICIN | 100052544 |